Child Neurology: A Case of FHL1 -Related Disease Presenting as Inflammatory Myopathy
- 2 March 2021
- journal article
- editorial
- Published by Ovid Technologies (Wolters Kluwer Health) in Neurology
- Vol. 96 (9), e1383-e1386
- https://doi.org/10.1212/wnl.0000000000011320
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Concurrent positive anti-3-hydroxy-3-methylglutaryl-coenzyme a reductase antibody with reducing body myopathy: Possible double troubleNeuromuscular Disorders, 2019
- Pediatric necrotizing myopathy associated with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodiesRheumatology, 2016
- The juvenile idiopathic inflammatory myopathies: pathogenesis, clinical and autoantibody phenotypes, and outcomesJournal of Internal Medicine, 2016
- Development of autoantibodies against muscle-specific FHL1 in severe inflammatory myopathiesJCI Insight, 2015
- 199th ENMC international workshop: FHL1 related myopathies, June 7–9, 2013, Naarden, The NetherlandsNeuromuscular Disorders, 2014
- Novel FHL1 mutation in a family with reducing body myopathyMuscle & Nerve, 2012
- Myositis or dystrophy? Traps and pitfallsLa Presse Médicale, 2011
- Proteomic identification of FHL1 as the protein mutated in human reducing body myopathyJCI Insight, 2008
- Clinical, histological and genetic characterization of reducing body myopathy caused by mutations in FHL1Brain, 2008
- Reducing body myopathyNeurology, 1972